During the first senotherapeutics conference organized by the Phaedon Institute at the Buck Institute for Research on Aging (Novato, CA), experts on the molecular and cellular mechanisms of aging, pathogenesis of age-related diseases, and drug discovery and development convened to delve into ideas on the past, present, and future of targeting senescent cells. The summit was divided into four sessions: basic biology, preclinical, clinical, and early-stage companies. Panel discussions covering large pharma, biomarkers, and investments in the field were organized between sessions….
Quarta, M., Demaria, M. On the past, present and future of senotherapeutics. npj Aging 10, 11 (2024)
By bringing together influential stakeholders from academia, industry, government agencies and investment organizations, the summit, which is titled Past, Present & Future of the Science of Cellular Senescence and the Therapeutics, aims to create a forum of discussion that will promote synergy and co-operation in the senotherapeutics space.
…
A new longevity non-profit organization emerged from stealth today with the goal of enabling effective and sustainable growth in the longevity industry. The Phaedon Institute brings together top minds from across the field of aging science, promoting synergy, cooperation, and discussion to support the development of rigorous standards and guidance for the field.
…
One of the more noted figures in the senolytics industry has founded a think-tank institute to promote longevity science, and is organizing a senotherapeutics conference to take place later this year. This seems a good thing, and I encourage more of those in the industry to step outside the bounds of their company research and development programs to consider the bigger picture and what they might do to cultivate faster progress towards greater human longevity.
…
A new institute focused on Longevity…
